TELA Bio, Inc. Preferred Stock, Accretion of Redemption Discount
TELA Bio, Inc. (TELA) reported Preferred Stock, Accretion of Redemption Discount of $7.78 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-23.
Discontinued › Shareholders' Equity
us-gaap:PreferredStockAccretionOfRedemptionDiscount · last filed 2022-03-23
- TELA Bio, Inc. preferred stock, accretion of redemption discount for the quarter ending 2019-12-31 was $940.00K, a 52.41% decline year-over-year.
- TELA Bio, Inc. preferred stock, accretion of redemption discount for the quarter ending 2019-09-30 was $2.06M, a 9.99% increase year-over-year.
- TELA Bio, Inc. preferred stock, accretion of redemption discount for the quarter ending 2019-06-30 was $2.76M.
- TELA Bio, Inc. preferred stock, accretion of redemption discount for the quarter ending 2019-03-31 was $2.02M.
- TELA Bio, Inc. preferred stock, accretion of redemption discount for fiscal 2019 was $7.78M, a 11.79% decline from fiscal 2018.
- TELA Bio, Inc. preferred stock, accretion of redemption discount for fiscal 2018 was $8.82M, a 49.72% increase from fiscal 2017.
- TELA Bio, Inc. preferred stock, accretion of redemption discount for fiscal 2017 was $5.89M.
| Period end | Preferred Stock, Accretion of Redemption Discount 3 month | Preferred Stock, Accretion of Redemption Discount 6 month | Preferred Stock, Accretion of Redemption Discount 9 month | Preferred Stock, Accretion of Redemption Discount 12 month |
|---|---|---|---|---|
| 2019-12-31 | $940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $3.00M derived: sum of 2 quarters · filed 2022-03-23 | $5.76M derived: sum of 3 quarters · filed 2022-03-23 | $7.78M 10-K · filed 2022-03-23 |
| 2019-09-30 | $2.06M 10-Q · filed 2020-11-12 | $4.82M derived: sum of 2 quarters · filed 2020-11-12 | $6.84M 10-Q · filed 2020-11-12 | $8.82M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | $2.76M 10-Q · filed 2020-08-13 | $4.79M 10-Q · filed 2020-08-13 | $6.76M derived: sum of 3 quarters · filed 2021-03-25 | $8.63M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-03-31 | $2.02M 10-Q · filed 2020-05-15 | $4.00M derived: sum of 2 quarters · filed 2021-03-25 | $5.87M derived: sum of 3 quarters · filed 2021-03-25 | |
| 2018-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $3.85M derived: sum of 2 quarters · filed 2021-03-25 | $8.82M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $1.87M 10-Q · filed 2019-12-18 | $6.85M 10-Q · filed 2019-12-18 | ||
| 2017-12-31 | $5.89M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |